Stewart-Treves Syndrome: A Rare But Aggressive Complication of Breast Cancer-Related Lymphedema.

Breast cancer Stewart-Treves syndrome lymphangiosarcoma lymphedema

Journal

European journal of breast health
ISSN: 2587-0831
Titre abrégé: Eur J Breast Health
Pays: Turkey
ID NLM: 101709357

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 25 04 2020
accepted: 22 06 2020
entrez: 15 10 2021
pubmed: 16 10 2021
medline: 16 10 2021
Statut: epublish

Résumé

Stewart-Treves syndrome (STS) is an angiosarcoma that usually develop in an extremity with longstanding lymphedema. Most affected patients have a history of breast cancer treated with radical mastectomy. Here, we report a case of STS with breast cancer-related lymphedema (BCRL) for a period of seven years. A 56-year-old woman presented with chronic lymphedema of the left arm. Nine years previously she had modified radical mastectomy for grade 2, invasive, ductal breast cancer. Upon physical examination, a tender, purplish lesion on the medial half of the affected arm was observed. The lesion spread rapidly with different-sized, scattered, purple-colored lesions in the affected area. A prompt skin biopsy was reported as STS. An immediate arm amputation was performed. However, a few months later she presented with new lesions on the anterior thorax and subsequent local recurrence around the scar. She received radiation-therapy. However, six months later the angiosarcoma had spread to the pelvic and upper limb area with scattered skin lesions. She had several problems during the chemotherapy and radiation-therapy, although she survived beyond 20 months. In conclusion, STS is a rare but aggressive and important complication of BCRL. Awareness of rapidly progressing skin lesions and detailed investigation, as well as prompt surgery is necessary for patients with BCRL in order to relatively increase the survival time.

Identifiants

pubmed: 34651118
doi: 10.4274/ejbh.galenos.2020.5741
pii: 42766
pmc: PMC8496122
doi:

Types de publication

Case Reports

Langues

eng

Pagination

378-382

Informations de copyright

©Copyright 2021 by Turkish Federation of Breast Diseases Associations.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors have no conflicts of interest to declare.

Références

J Clin Diagn Res. 2016 Feb;10(2):WD01-2
pubmed: 27042566
J Breast Health. 2015 Apr 1;11(2):92-94
pubmed: 28331699
An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):229-31
pubmed: 26312725
Cancer. 1948 May;1(1):64-81
pubmed: 18867440
Malays J Med Sci. 2014 Sep-Oct;21(5):66-70
pubmed: 25977636
Case Rep Surg. 2017;2017:4056459
pubmed: 28280645
Case Rep Oncol. 2016 Apr 01;9(1):205-11
pubmed: 27099606
J Surg Oncol. 2020 Jan;121(1):85-90
pubmed: 31236970
Int J Clin Exp Pathol. 2019 Mar 01;12(3):680-688
pubmed: 31933875
Clin Dermatol. 2014 Sep-Oct;32(5):616-20
pubmed: 25160102
J Am Acad Dermatol. 2012 Dec;67(6):1342-8
pubmed: 22682884
Case Rep Pathol. 2013;2013:931973
pubmed: 24078891
Int Angiol. 2019 Aug;38(4):334-342
pubmed: 31203598
An Bras Dermatol. 2017 Mar-Apr;92(2):235-238
pubmed: 28538886
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11108-15
pubmed: 26617830
Oncol Lett. 2018 Jan;15(1):1113-1118
pubmed: 29391898
Lymphat Res Biol. 2016 Mar;14(1):35-9
pubmed: 26584023

Auteurs

Pınar Borman (P)

Clinic of Physical Medicine and Rehabilitation, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.

Ayşegül Yaman (A)

Clinic of Physical Medicine and Rehabilitation, Gülhane Training and Reseach Hospital, Ankara, Turkey.

Özay Gököz (Ö)

Department of Pathology, University of Hacettepe Faculty of Medicine, Ankara, Turkey.

Classifications MeSH